Zomig - Treatment of Acute Migraine Headache in Adolescents

Summary

The purpose of this study is to investigate if Zomig® Nasal Spray will help children (age 12-17 years) with migraine headaches feel better. This will be done by comparing 3 different doses of Zomig Nasal Spray with placebo nasal spray (inactive treatment).

Timeline

Start

2010-09

Primary completion

2013-10

Completion

2013-10

Outcome

Met primary endpoint

registry analysis (superiority or other test); Placebo vs ZOMIG 5 mg; p <.001; Odds Ratio (OR) 2.18 (95% CI 1.40 to 3.39); Regression, Logistic; note: Unadjusted NCT01211145 ↗

Drugs

Indications